183 related articles for article (PubMed ID: 9069109)
21. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?
Heeringa P; Huugen D; Tervaert JW
Trends Immunol; 2005 Nov; 26(11):561-4. PubMed ID: 16139567
[TBL] [Abstract][Full Text] [Related]
22. Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion.
Radford DJ; Savage CO; Nash GB
Arthritis Rheum; 2000 Jun; 43(6):1337-45. PubMed ID: 10857792
[TBL] [Abstract][Full Text] [Related]
23. Testing on formalin-fixed neutrophils is less sensitive and specific for small vessel vasculitis, and less sensitive for MPO-ANCA, than most ELISAs.
Pollock W; Trevisin M; Savige J;
J Immunol Methods; 2008 Dec; 339(2):141-5. PubMed ID: 18823991
[TBL] [Abstract][Full Text] [Related]
24. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
Schultz H; Weiss J; Carroll SF; Gross WL
J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
Heeringa P; Tervaert JW
Kidney Int; 2004 May; 65(5):1564-7. PubMed ID: 15086893
[TBL] [Abstract][Full Text] [Related]
26. Translating basic science into patient therapy for ANCA-associated small vessel vasculitis.
Williams JM; Kamesh L; Savage CO
Clin Sci (Lond); 2005 Feb; 108(2):101-12. PubMed ID: 15504102
[TBL] [Abstract][Full Text] [Related]
27. ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?
van der Veen BS; Heeringa P
APMIS Suppl; 2009 Jun; (127):21-6. PubMed ID: 19515135
[TBL] [Abstract][Full Text] [Related]
28. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.
Hu N; Westra J; Kallenberg CG
Autoimmun Rev; 2009 May; 8(6):510-4. PubMed ID: 19185066
[TBL] [Abstract][Full Text] [Related]
29. How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
Kettritz R
Clin Exp Immunol; 2012 Sep; 169(3):220-8. PubMed ID: 22861361
[TBL] [Abstract][Full Text] [Related]
30. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
Reynolds WF; Stegeman CA; Tervaert JW
Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of ANCA-Associated Pulmonary Vasculitis.
Alba MA; Jennette JC; Falk RJ
Semin Respir Crit Care Med; 2018 Aug; 39(4):413-424. PubMed ID: 30404109
[TBL] [Abstract][Full Text] [Related]
32. The role of the endothelium in systemic small vessel vasculitis.
Little MA; Savage CO
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S135-40. PubMed ID: 18799071
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil FcgammaRIIIb allelic polymorphism in anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis.
Tse WY; Abadeh S; Jefferis R; Savage CO; Adu D
Clin Exp Immunol; 2000 Mar; 119(3):574-7. PubMed ID: 10691933
[TBL] [Abstract][Full Text] [Related]
34. Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA).
Yang JJ; Preston GA; Alcorta DA; Waga I; Munger WE; Hogan SL; Sekura SB; Phillips BD; Thomas RP; Jennette JC; Falk RJ
Kidney Int; 2002 Nov; 62(5):1638-49. PubMed ID: 12371964
[TBL] [Abstract][Full Text] [Related]
35. Pathogenic potential of anti-neutrophil cytoplasmic autoantibodies.
Jennette JC
Lab Invest; 1994 Feb; 70(2):135-7. PubMed ID: 8139256
[No Abstract] [Full Text] [Related]
36. Pathogenesis of ANCA-associated vasculitis.
Flint J; Morgan MD; Savage CO
Rheum Dis Clin North Am; 2010 Aug; 36(3):463-77. PubMed ID: 20688244
[TBL] [Abstract][Full Text] [Related]
37. The role of neutrophils in causing antineutrophil cytoplasmic autoantibody-associated vasculitis.
Schreiber A; Choi M
Curr Opin Hematol; 2015 Jan; 22(1):60-6. PubMed ID: 25394311
[TBL] [Abstract][Full Text] [Related]
38. New developments in the pathogenesis of ANCA-associated vasculitis.
Day CJ; Hewins P; Savage CO
Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S35-48. PubMed ID: 14740426
[TBL] [Abstract][Full Text] [Related]
39. Understanding the pathogenesis of ANCA: where are we today?
Preston GA; Yang JJ; Xiao H; Falk RJ
Cleve Clin J Med; 2002; 69 Suppl 2():SII51-4. PubMed ID: 12086265
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitis.
Pankhurst T; Savage CO
Curr Opin Pharmacol; 2006 Apr; 6(2):190-6. PubMed ID: 16483847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
